Security Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $2.43M | Buy |
15,242
+34
| +0.2% | +$5.2K | 1.42% | 27 |
|
|
2022
Q4 | $2.46M | Buy |
15,208
+220
| +1% | +$33.7K | 1.36% | 33 |
|
|
2022
Q3 | $2.01M | Sell |
14,988
-220
| -1% | -$31.6K | 1.21% | 34 |
|
|
2022
Q2 | $2.33M | Buy |
15,208
+1,144
| +8% | +$175K | 1.28% | 34 |
|
|
2022
Q1 | $2.28M | Buy |
14,064
+220
| +2% | +$32K | 0.98% | 40 |
|
|
2021
Q4 | $1.87M | Sell |
13,844
-220
| -2% | -$26K | 0.73% | 46 |
|
|
2021
Q3 | $1.52M | Buy |
14,064
+220
| +2% | +$25.1K | 0.61% | 48 |
|
|
2021
Q2 | $1.56M | Sell |
13,844
-2,284
| -14% | -$257K | 0.61% | 48 |
|
|
2021
Q1 | $1.75M | Sell |
16,128
-144
| -0.9% | -$15.4K | 0.72% | 47 |
|
|
2020
Q4 | $1.74M | Buy |
16,272
+2,625
| +19% | +$252K | 0.73% | 46 |
|
|
2020
Q3 | $1.2M | Sell |
13,647
-1,747
| -11% | -$164K | 0.73% | 44 |
|
|
2020
Q2 | $1.51M | Hold |
15,394
| – | – | 0.93% | 42 |
|
|
2020
Q1 | $1.17M | Sell |
15,394
-56
| -0.4% | -$4.77K | 0.83% | 42 |
|
|
2019
Q4 | $1.37M | Hold |
15,450
| – | – | 0.82% | 42 |
|
|
2019
Q3 | $1.17M | Hold |
15,450
| – | – | 0.77% | 41 |
|
|
2019
Q2 | $1.12M | Sell |
15,450
-470
| -3% | -$36.9K | 0.72% | 45 |
|
|
2019
Q1 | $1.28M | Hold |
15,920
| – | – | 0.85% | 41 |
|
|
2018
Q4 | $1.47M | Hold |
15,920
| – | – | 1.12% | 39 |
|
|
2018
Q3 | $1.51M | Buy |
15,920
+390
| +3% | +$37K | 0.99% | 41 |
|
|
2018
Q2 | $1.44M | Hold |
15,530
| – | – | 1.02% | 38 |
|
|
2018
Q1 | $1.47M | Sell |
15,530
-900
| -5% | -$98.9K | 1.1% | 37 |
|
|
2017
Q4 | $1.59M | Hold |
16,430
| – | – | 1.2% | 35 |
|
|
2017
Q3 | $1.46M | Hold |
16,430
| – | – | 1.15% | 35 |
|
|
2017
Q2 | $1.19M | Hold |
16,430
| – | – | 0.98% | 39 |
|
|
2017
Q1 | $1.07M | Sell |
16,430
-639
| -4% | -$40.2K | 0.92% | 41 |
|
|
2016
Q4 | $1.07M | Sell |
17,069
-663
| -4% | -$40.5K | 0.99% | 41 |
|
|
2016
Q3 | $1.12M | Hold |
17,732
| – | – | 1.05% | 39 |
|
|
2016
Q2 | $1.1M | Hold |
17,732
| – | – | 1.05% | 39 |
|
|
2016
Q1 | $1.01M | Buy |
17,732
+470
| +3% | +$26.2K | 0.99% | 41 |
|
|
2015
Q4 | $1.02M | Hold |
17,262
| – | – | 0.99% | 40 |
|
|
2015
Q3 | $939K | Hold |
17,262
| – | – | 1% | 38 |
|
|
2015
Q2 | $1.16M | Hold |
17,262
| – | – | 1.07% | 40 |
|
|
2015
Q1 | $1.01M | Hold |
17,262
| – | – | 0.96% | 41 |
|
|
2014
Q4 | $1.13M | Buy |
+17,262
| New | +$1.09M | 1.12% | 38 |
|
Other funds holding ABBV
Security Asset Management's ABBV Position: Q1 2023 in Review
Security Asset Management increased its AbbVie (ABBV) stake by 0.22% in Q1 2023, buying an estimated $5.2K and bringing the position to 15,242 shares worth $2.43M. The position accounts for 1.42% of the portfolio, ranked #27.
Security Asset Management first reported a position in ABBV in Q4 2014 and has held it in 34 quarters since. The position peaked at $2.46M in Q4 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.
- Security Asset Management held 15,242 shares of AbbVie worth $2.43M as of Q1 2023.
- Security Asset Management bought 34 AbbVie shares in Q1 2023, an estimated $5.2K.
- AbbVie made up 1.42% of Security Asset Management's portfolio in Q1 2023, its #27 holding.
- Security Asset Management first reported a position in AbbVie in Q4 2014 and has held it in 34 quarters since.
- Security Asset Management's AbbVie position peaked at $2.46M in Q4 2022.
- 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.
Based on Security Asset Management's 13F filing for Q1 2023, filed 12 May 2023.